HOME > 教室について > 業績リスト > 【学会発表】国際学会 > 2011年

2011年

ACC Scientific Session April 2-5, 2011 New Orleans, Florida
  1. Neiko Ozasa, Takeshi Morimoto, Bao Bingyuan, Tetsuo Shioi, Takeshi Kimura. Effect of Passive Cycling on Systemic Endothelial Function in Elderly Patients with Heart Failure: A Pilot Report
  2. Junichi Tazaki, Nobuya Higashiani, Takeshi Kimura: Successful revascularization of SMA total occlusion supported by CT and IVUS
Angioplasty Summit TCTAP 2011 April 27-29, 2011 Seoul
  1. Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Masashi Iwabuchi, Satoshi Shizuta, Toru Kita, Takeshi Kimura: Comparison of three-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention
国際RNA学会　日本RNA学会　平成23年6月14-18日　京都
  1. Takahiro Horie, Koh Ono, Takeshi Kimura: MicroRNA-33 encoded by an intron of Srebp2 regulates HDL in vivo.
  2. Yasuhide Kuwabara, Koh Ono, Takahiro Horie, Hitoo Nishi, Minako　Kinoshita, Shin Watanabe, Osamu Baba, Toru Kita Takeshi Kimura: Elevated MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients with Cardiovascular Diseases Indicates the Myocardial Damage.
  3. Koh Ono, Takahiro Horie, Hitoo Nishi, Minako Kinoshita, Shin Watanabe, Yasuhide　Kuwabara, Toru Kita: MiR-146a-induced Inhibition of Neuragulin1-ErbB4 pathway may be involved in Deterioration of Cardiomyopathy under Concurrent Chemotherapy with Doxorubicin and Trastuzumab.
The ninth Annual Scientific Sessions, Society for Heart and Vascular Metabolism, June 18-21, 2011, Brussels, Belgium
  1. Shioi T. Role of phosphoinositide 3-kinase in cardiac aging.
Gordon Research Conference (Regulated Proteolysis of Cell Surface Proteins) July 10 – 15, 2011, Davidson, North Carolina
  1. Nishi E.: Multiple pathophysiological roles of nardilysin, an enhancer of ectodomain shedding (Invited lecture)
心血管腎臓国際フォーラム　平成23年7月15日　京都
  1. Koh Ono, MicroRNAs: Roles and clinical applications in cardiovascular diseases.
AAICAD (Alzheimer's Association International Conference on Alzheimer's Disease) July 16-21, 2011 Paris, France
  1. Ohno M, Hiraoka Y, Matsuoka T, Nishi K, Saijo S, Kimura T, and Nishi E: Nardilysin prevents amyloid plaque formation by enhancingα-secretase activity in vivo.
10th Biennial ISN Satellite Meeting on Myelin Biology August 24 – 27, 2011 Kolymvari, Crete, Greece
  1. Nishi E: Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system (Invited Lecture)
  2. Ohno M, Nishi E.: Demyelination and remyelination are distinctly regulated by nardilysin in the murine cuprizone model (Poster presentation)
European Society of Cardiology Congress 2011 August 27-31, Paris, France
  1. Nagao K, Ono K, Horie T, Tamaki Y, Iwanaga Y, Makita T, Inada T, Tanaka M, Kita T, Kimura T. Neural cell adhesion molecule is a cardioprotective factor upregulated by metabolic stress.
  2. Wada H, Satoh-Asahara N, Akao M, Abe M, Ono K, Morimoto T, Fujita M, Shimatsu A, Takahashi Y, Hasegawa K. Aloha1 anti-trypsin-low-density-lipoprotein serves as a marker of smoking-specific oxidative stress.
  3. Kuwabara Y, Ono K, Horie T, Nishi H, Watanabe S, Kinoshita M, Baba O, Kita T, Kimura T. Elevated MicroRNA-1 and microRNA-133a in serum of patients with cardiovascular disease indicate the myocardial damage.
  4. Watanabe S, Ono K, Horie T, Nishi H, Kuwabara Y, Baba O, Kimura T. CMKK beta contributes to energy supply in adaptive phase of pressure-overload-induced heart failure.
  5. Kishimoto C, Shimada K, Okabe T, Hattori M, Fujita M: Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, accelerates healing process.
  6. Kishimoto C, Yuan Z, Shioji K: Beneficial effects of low-dose benidipine in acute autoimmune myocarditis.
  7. Kishimoto C, Shimada K, Hirano E, Komiyama T, Fujita M: Erythromycin treatment suppressed myocardial injury in autoimmune myocarditis.
  8. Kishimoto C, Shimada K, Murayama T, Yokode M, Fujita M: Unstable plaques induced by marble-burying behavior are stabilized by exercise training in experimental atherosclerosis.
  9. Kishimoto C, Okabe T, Shimada K, Murayama T, Yokode M: Swimming reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by antioxidant effects.
  10. Tetsuhisa Hattori: Over-expression of heterozygous KCNJ2-M301K channels, identified in a patient with short QT syndrome.
  11. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K.: Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation.
  12. Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Masashi Iwabuchi, Satoshi Shizuta, Toru Kita, Takeshi Kimura: Comparison of three-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention
  13. Hiroki Shiomi: Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
  14. Imai M, Kimura T, Kadota K , Mitsudo K: Impact of Angiographic Peri-Stent Contrast Staining (PSS) on Late Adverse Events After Sirolimus-Eluting Stent Implantation: an observation from the multicenter j-Cypher registry PSS substudy
  15. Hiroki Shiomi: Comparison of three-year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel coronary artery disease: an observation from the CREDO-Kyoto PCI/CABG registry Cohort-2
2011 AVDRC International Symposium, Intervention of Vascular Aging: New Frontiers, September 22, 2011. Daegu, Korea.
  1. Koh Ono, MicroRNA-33 Encoded by an Intron of Srebp2 Regulates HDL in vivo.
Transcatheter Cardiovascular Therapeutics 23rd Annual Scientific Symposium November 7-11, 2011 San Francisco, California
  1. Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura: Statin Therapy Reduces Late Target Lesion Revascularization after Sirolimus-eluting Stent Implantation
  2. Hiroki Shiomi: A Large-scale, Multicenter Registry Comparing the Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients with Left Main Disease
American Heart Association Annual Scientific Sessions 2011, November 12-16, Orlando, Florida
  1. Sowa N, Ono K, Horie T, Hasegawa K, Kimura T: MicroRNA 26b encoded by the introns of small CTD Phosphatases (SCPs) 1 has an antagonistic effect on its host gene and suppresses cardiac hypertrophy.
  2. Kuwabara Y, Ono K, Horie T, Nishi H, Watanabe S, Kinoshita M, Baba O, Chujo Y, Nagao K, Kojima Y, Kita T, Kimura T: MicroRNA-1 and microRNA-133a elevations in serum of patients with cardiovascular disease indicate the existence of myocardial damage.
  3. Wada H, Ura S, Masunaga N, Akao M, Abe M, Funatsu J, Nakajima Y, Kanasaki M, Nakano T, Ono K, Morimoto T, Shimatsu A, Hasegawa K: Soluble vascular endothelial growth factor receptor-1 serves as a marker of cardiovascular risk in chronic kidney disease patients.
  4. Kato T, Shioi T, Niizuma S, Kawashima T, Okuda J, Kawamoto A, Tamaki Y, Iwanaga Y, Soga T, Kita T, Kimura T: Cardiac cachexia is associated with abnormal liver metabolism and pro-inflammatory responses in a rat model of heart failure
  5. Kawamoto A, Shioi T, Kato T, Niizuma S, Kawashima T, Okuda J, Tanada Y, Tamaki Y, Kimura T: Tc-99m sestamibi is a useful noninvasive method to assess cardiac mitochondrial function in vivo.
  6. Ohno M, Hiraoka Y, Matsuoka T, Nishi K, Saijo S, Kimura T, and Nishi E: Nardilysin regulates circulatory dynamics through modulating sympathetic nerve innervation
  7. Takeru Makiyama: Analysis of Cardiomyocytes Differentiated from Disease-specific Induced Pluripotent Stem Cells from a Patient with Lamin A/C-related Cardiomyopathy.
  8. Kishimoto C, Yuan Z: Pioglitazone ameliorates atherosclerotic lesions with the modification of the balance of effector and regulatory T cells in apolipoprotein E deficient mice.
  9. Neiko Ozasa, Takeshi Morimoto, Bao Bingyuan, Satoshi Shizuta, Tomohisa Tada, Junichi Tazaki, Hiroki Shiomi, Yoshihiro Kato, Mamoru Hayano, Akihiro Tokushige, Masahiro Natsuaki, Tetsu Nakajima, Takeshi Kimura: Beta-Blocker Therapy is Associated with Worse 3-Year Clinical Outcomes in Patients who Underwent Percutaneous Coronary Intervention but No History of Myocardial Infarction or Heart Failure
Atherosclerosis advisory board, November 17, 2011, Orland, Florida
  1. Koh Ono, MicroRNA-33 Encoded by an Intron of Srebp2 Regulates HDL in vivo.
The 28th Annual Meeting: Japanese Section of the International Society for Heart Research December 2-3, 2011, Tokyo, Japan
  1. Shioi T, Analysis of cardiac and systemic metabolic remodeling in heart failure.
  2. Okuda J, Niizuma S, Inuzuka Y, Kato T, Kawashima T, Tamaki Y, Kawamoto A, Tanada Y, Narazaki M, Matsuda T, Kondoh H, Kita T, Kimura T, Shioi T. Cardiac-specific overexpression of phosphoglycerate mutase, a glycolytic enzyme, induces pro-inflammatory response and cardiac dysfunction in mice.
<< 2010年｜ 業績リストTOP ｜2012年 >>
ページの先頭へ